It is a trading private limited company based in Haryana, Haryana, India, established in 2001.
2001 | Haryana, Haryana, India | ActiveGrampus Pharmaceuticals Private Limited, a active private limited company, was established on 05 March 2001 in Haryana, Haryana, India. Engaging in wholesale within the trade sector, it holds CIN: U24231HR2001PTC034631. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.75 M.
It upholds a compliant status. Its leadership includes Manav Maini (Director), Pawan Kumar Maini (Managing Director). Past directors included Puneet Kumar Batra. It holds no open charges and ₹2.80 M settled loans. Its latest AGM occurred on 04 September 2025, with the balance sheet filed on 31 March 2025. It is based at 14 Bank Colonyambala City, Haryana, Haryana, 134003.
U24231HR2001PTC034631
034631
05 March 2001
₹1.00 M
₹0.75 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Grampus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manav Maini | Director | 17 Nov 2008 | Current |
| Pawan Kumar Maini | Managing Director | 05 Mar 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Nov 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Grampus Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 1172.51% increase. The company also saw a substantial fall in profitability, with a 4700.78% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1704.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Grampus Pharmaceuticals had a promoter holding of 94.67% and a public holding of 5.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Oct 2008 | State Bank Of India | ₹0.30 M | Satisfied |
| 04 Jan 2008 | State Bank Of India | ₹0.20 M | Satisfied |
| 30 Jun 2007 | State Bank Of India | ₹0.30 M | Satisfied |
| 23 Dec 2004 | State Bank Of India | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Grampus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Grampus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grampus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Grampus Pharmaceuticals Private Limited last Annual general meeting of members was held on 04 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Grampus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
Progress on A charge registered on 23 Dec 2004 via Charge ID 90369547 with State Bank Of India was fully satisfied on 16 Apr 2015. was documented.
A charge registered on 20 Oct 2008 via Charge ID 10130881 with State Bank Of India was fully satisfied on 28 Feb 2015. was recorded as a recent event.
The activity A charge registered on 04 Jan 2008 via Charge ID 10085021 with State Bank Of India was fully satisfied on 23 Sep 2011. was completed.
A charge registered on 30 Jun 2007 via Charge ID 10086676 with State Bank Of India was fully satisfied on 23 Sep 2011. was recorded as a recent event.
The CIN of Grampus Pharmaceuticals Private Limited is U24231HR2001PTC034631.
Grampus Pharmaceuticals Private Limited is headquartered at 14 Bank Colonyambala City, Haryana, Haryana, 134003.
Grampus Pharmaceuticals Private Limited was incorporated on 05 March 2001.
The current directors of Grampus Pharmaceuticals Private Limited are
The primary industry of Grampus Pharmaceuticals Private Limited is Trade.
Grampus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Grampus Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.75 M.
The compliance status of Grampus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX